Literature DB >> 21222134

The role of surveillance cultures in the prediction of susceptibility patterns of Gram-negative bacilli in the intensive care unit.

H Baba1, G R Nimmo, A M Allworth, R J Boots, Y Hayashi, J Lipman, D L Paterson.   

Abstract

Surveillance cultures may detect colonisation with drug-resistant Gram-negative bacteria and can be hypothesised to guide appropriate initial antibiotic treatment for intensive care unit (ICU) patients. We investigated the microbiological data of 228 episodes of nosocomial bloodstream infection (BSI) due to Gram-negative bacteria in an ICU in which piperacillin/tazobactam or meropenem was used empirically for serious infections, to evaluate the contribution of surveillance cultures to an appropriate choice of initial antibiotic therapy. Surveillance cultures were taken in advance of BSI in 218 (95.6%) of 228 episodes. Concordant organisms with identical identification and susceptibilities were found in prior surveillance cultures and subsequent blood cultures in 65 (29.8%) of 218 episodes. Surveillance cultures predicted resistance in 52.9% and 51.4% of BSIs caused by resistant pathogens to piperacillin/tazobactam and meropenem, respectively. The negative predictive value of surveillance cultures negative for a resistant organism also exceeded 90% for piperacillin/tazobactam and meropenem. Given that the overall resistant rates of BSI pathogens of our study were 11.3% to piperacillin/tazobactam and 16.4% to meropenem, surveillance cultures in our setting may provide important information on the probability of drug resistance of the causative pathogens and some utility in aiding empiric antibiotic therapy for ICU patients who subsequently develop BSI.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21222134     DOI: 10.1007/s10096-010-1146-1

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  18 in total

1.  Outcome in bacteremia associated with nosocomial pneumonia and the impact of pathogen prediction by tracheal surveillance cultures.

Authors:  Pieter Depuydt; Dominique Benoit; Dirk Vogelaers; Geert Claeys; Gerda Verschraegen; Koenraad Vandewoude; Johan Decruyenaere; Stijn Blot
Journal:  Intensive Care Med       Date:  2006-09-16       Impact factor: 17.440

Review 2.  Management of multidrug-resistant organisms in health care settings, 2006.

Authors:  Jane D Siegel; Emily Rhinehart; Marguerite Jackson; Linda Chiarello
Journal:  Am J Infect Control       Date:  2007-12       Impact factor: 2.918

3.  Previous cultures are not clinically useful for guiding empiric antibiotics in suspected ventilator-associated pneumonia: secondary analysis from a randomized trial.

Authors:  Kevin M Sanders; Neill K J Adhikari; Jan O Friedrich; Andrew Day; Xuran Jiang; Daren Heyland
Journal:  J Crit Care       Date:  2008-03       Impact factor: 3.425

Review 4.  The use of active surveillance cultures in adult intensive care units to reduce methicillin-resistant Staphylococcus aureus-related morbidity, mortality, and costs: a systematic review.

Authors:  Katharine L McGinigle; Margaret L Gourlay; Ian B Buchanan
Journal:  Clin Infect Dis       Date:  2008-06-01       Impact factor: 9.079

5.  Colonization status and appropriate antibiotic therapy for nosocomial bacteremia caused by antibiotic-resistant gram-negative bacteria in an intensive care unit.

Authors:  Stijn Blot; Pieter Depuydt; Dirk Vogelaers; Johan Decruyenaere; Jan De Waele; Eric Hoste; Renaat Peleman; Geert Claeys; Gerda Verschraegen; Francis Colardyn; Koenraad Vandewoude
Journal:  Infect Control Hosp Epidemiol       Date:  2005-06       Impact factor: 3.254

6.  Role of serial routine microbiologic culture results in the initial management of ventilator-associated pneumonia.

Authors:  Jan Hayon; Corinne Figliolini; Alain Combes; Jean-Louis Trouillet; Najibi Kassis; Marie Christine Dombret; Claude Gibert; Jean Chastre
Journal:  Am J Respir Crit Care Med       Date:  2002-01-01       Impact factor: 21.405

7.  Principles of antibiotic therapy in severe infections: optimizing the therapeutic approach by use of laboratory and clinical data.

Authors:  Stan Deresinski
Journal:  Clin Infect Dis       Date:  2007-09-15       Impact factor: 9.079

8.  Ventilator-associated pneumonia after heart surgery: a prospective analysis and the value of surveillance.

Authors:  Emilio Bouza; Ana Pérez; Patricia Muñoz; M Jesús Pérez; Cristina Rincón; Carlos Sánchez; Pablo Martín-Rabadán; Mariano Riesgo
Journal:  Crit Care Med       Date:  2003-07       Impact factor: 7.598

Review 9.  Screening and isolation for infection control.

Authors:  E Tacconelli
Journal:  J Hosp Infect       Date:  2009-08-21       Impact factor: 3.926

10.  Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2009-03-20       Impact factor: 17.586

View more
  7 in total

Review 1.  Value of lower respiratory tract surveillance cultures to predict bacterial pathogens in ventilator-associated pneumonia: systematic review and diagnostic test accuracy meta-analysis.

Authors:  Nele Brusselaers; Sonia Labeau; Dirk Vogelaers; Stijn Blot
Journal:  Intensive Care Med       Date:  2012-11-28       Impact factor: 17.440

2.  Predictive value of surveillance cultures for bacteremia caused by extended-spectrum beta-lactamase (ESBL)-producing Enterobacterales among patients with hematological diseases.

Authors:  Takuya Hattori; Tatsunori Goto; Masahide Osaki; Yukiyasu Ozawa; Koichi Miyamura
Journal:  Infection       Date:  2022-01-10       Impact factor: 3.553

3.  Risk factors and outcomes of Stenotrophomonas maltophilia bacteraemia: a comparison with bacteraemia caused by Pseudomonas aeruginosa and Acinetobacter species.

Authors:  Go Hotta; Yasufumi Matsumura; Karin Kato; Satoshi Nakano; Tomoyuki Yunoki; Masaki Yamamoto; Miki Nagao; Yutaka Ito; Shunji Takakura; Satoshi Ichiyama
Journal:  PLoS One       Date:  2014-11-06       Impact factor: 3.240

4.  Derivation and validation of a simple score to predict the presence of bacteria requiring carbapenem treatment in ICU-acquired bloodstream infection and pneumonia: CarbaSCORE.

Authors:  Laura Teysseyre; Cyril Ferdynus; Guillaume Miltgen; Thomas Lair; Thomas Aujoulat; Nathalie Lugagne; Nicolas Allou; Jérôme Allyn
Journal:  Antimicrob Resist Infect Control       Date:  2019-05-20       Impact factor: 4.887

5.  Active Surveillance Cultures and Procalcitonin in Combination With Clinical Data to Guide Empirical Antimicrobial Therapy in Hospitalized Medical Patients With Sepsis.

Authors:  Silvia Spoto; John Daniel Markley; Emanuele Valeriani; Antonio Abbate; Josepmaria Argemi; Roshanak Markley; Marta Fogolari; Luciana Locorriere; Giuseppina Beretta Anguissola; Giulia Battifoglia; Sebastiano Costantino; Massimo Ciccozzi; César Bustos Guillén; Silvia Angeletti
Journal:  Front Microbiol       Date:  2022-04-07       Impact factor: 6.064

6.  A survey on infection management practices in Italian ICUs.

Authors:  Matteo Bassetti; Raffaele De Gaudio; Teresita Mazzei; Giulia Morace; Nicola Petrosillo; Pierluigi Viale; Giuseppe Bello; Sofia La Face; Massimo Antonelli
Journal:  Crit Care       Date:  2012-11-15       Impact factor: 9.097

Review 7.  Antibiotics in critically ill children-a narrative review on different aspects of a rational approach.

Authors:  Nora Bruns; Christian Dohna-Schwake
Journal:  Pediatr Res       Date:  2021-12-06       Impact factor: 3.756

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.